{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:19:44Z","timestamp":1793765984049,"version":"4.6.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Accurate prediction of prognosis may improve management of patients with idiopathic membranous nephropathy. This study compared the Toronto Risk Score and urinary low-molecular weight proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>One hundred four patients with biopsy-proven idiopathic membranous nephropathy who presented between 1995 and 2008 with a well-preserved kidney function and nephrotic range proteinuria were included. Urinary \u03b22-microglobulin and \u03b11-microglobulin measurements were obtained by timed standardized measurements, and the Toronto Risk Score was calculated using data obtained from medical records. The endpoint was progression, which was defined as an increase in serum creatinine&gt;50% or &gt;25% with a concentration&gt;135 \u03bcmol\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-nine patients showed progression. The area under the receiver-operating characteristics curve was 0.78 (95% confidence interval=0.69\u20130.88) for the risk score versus 0.80 (0.71\u20130.89) and 0.79 (0.71\u20130.88) for urinary \u03b22- and \u03b11-microglobulin, respectively. Differences were not significant. Persistent proteinuria did not add accuracy to the Toronto Risk Score. Conversely, its accuracy was not reduced when data from the first 6 months of follow-up were used. Furthermore, a score based on GFR estimated with the six-variable Modification of Diet in Renal Disease equation, calculated in the first 6 months of follow-up, gave an area under the receiver-operating characteristics curve of 0.83 (0.74\u20130.92), which was not statistically different from other markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prognostic accuracies of the Toronto Risk Score and urinary low-molecular weight proteins were not significantly different. The risk score can be calculated within 6 months of diagnosis, and a simplified risk score using estimated GFR\u2013Modification of Diet in Renal Disease may be sufficient.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.00670112","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:40:05Z","timestamp":1337301605000},"page":"1242-1248","source":"Crossref","is-referenced-by-count":46,"title":["Prognostic Value of Risk Score and Urinary Markers in Idiopathic Membranous Nephropathy"],"prefix":"10.2215","volume":"7","author":[{"given":"Jan A.J.G.","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Hofstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230811","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2005.08.020","article-title":"Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy.","volume":"46","author":"du Buf-Vereijken","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R2-9-20230811","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2215\/CJN.04020411","article-title":"Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.","volume":"6","author":"van den Brand","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-9-20230811","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ki.1992.374","article-title":"Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis.","volume":"42","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"R4-9-20230811","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","article-title":"Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications.","volume":"51","author":"Cattran","year":"1997","journal-title":"Kidney Int"},{"key":"R5-9-20230811","first-page":"1553","article-title":"Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis.","volume":"9","author":"Honkanen","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"R6-9-20230811","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ki.1995.496","article-title":"Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy.","volume":"48","author":"Kon","year":"1995","journal-title":"Kidney Int"},{"key":"R7-9-20230811","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/ndt\/12.12.2562","article-title":"Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.","volume":"12","author":"Honkanen","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R8-9-20230811","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/ndt\/17.11.1890","article-title":"Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.","volume":"17","author":"Bazzi","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R9-9-20230811","first-page":"156","article-title":"Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?","volume":"23","author":"Ponticelli","year":"2010","journal-title":"J Nephrol"},{"key":"R10-9-20230811","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1681\/ASN.2004040287","article-title":"Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study.","volume":"16","author":"Branten","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R11-9-20230811","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/ndt\/gfn007","article-title":"Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R12-9-20230811","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ndt\/gfr371","article-title":"Management of patients with membranous nephropathy.","volume":"27","author":"Hofstra","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R13-9-20230811","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfp390","article-title":"Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: A randomized controlled trial.","volume":"25","author":"Hofstra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R14-9-20230811","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2362.1999.00422.x","article-title":"Atrial natriuretic peptide increases albuminuria in type I diabetic patients: Evidence for blockade of tubular protein reabsorption.","volume":"29","author":"Jacobs","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"R15-9-20230811","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R16-9-20230811","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/gfq443","article-title":"Estimated glomerular filtration rate in the nephrotic syndrome.","volume":"26","author":"Hofstra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R17-9-20230811","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfn190","article-title":"Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R18-9-20230811","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","article-title":"Statistical methods for assessment of added usefulness of new biomarkers.","volume":"48","author":"Pencina","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R19-9-20230811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.1998.v31.pm9428445","article-title":"Prognostic factors in idiopathic membranous nephropathy.","volume":"31","author":"Reichert","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R20-9-20230811","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.ki.5000289","article-title":"Renal pathology in idiopathic membranous nephropathy: A new perspective.","volume":"69","author":"Troyanov","year":"2006","journal-title":"Kidney Int"},{"key":"R21-9-20230811","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201208000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:10Z","timestamp":1786369330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201208000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00670112","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}